Literature DB >> 7355894

Alteration of pulmonary function in intravenous drug abusers. Prevalence, severity, and characterization of gas exchange abnormalities.

E S Overland, A J Nolan, P C Hopewell.   

Abstract

We examined the influence of chronic intravenous drug abuse on respiratory function in 512 consecutive drug addicts by obtaining respiratory histories, pulmonary function tests and chest roentgenograms. Two hundred and fourteen (42 per cent) had carbon monoxide-diffusing capacities (DLCO) of less than 75 per cent predicted (mean 65.7 per cent), and in 38 per cent reduced DLCO was the sole pulmonary function test abnormality. Obstructive lung disease attributed to asthma or chronic bronchitis was observed in 6 per cent and a restrictive defect due to interstitial lung disease was observed in 7 per cent. Exercise limitation due to dyspnea among those patients with altered pulmonary function was uncommon except in those with obstructive or restrictive lung disease. Roentgenographic evidence of pulmonary hypertension was not observed in any of the patients. Gas exchange measured at rest and during exercise in 11 patients with a low DLCO and in three patients with restrictive lung disease and a low DLCO revealed an increased alveolar-arterial oxygen difference but normal minute ventilation, dead space-to-tidal volume ratio and absence of abnormal right-to-left shunts. We conclude that alterations in pulmonary function in drug addicts due to foreign particle emboli are very common but that significant respiratory symptoms are unusual and that abnormalities in gas exchange during exercise are mild.

Entities:  

Mesh:

Year:  1980        PMID: 7355894     DOI: 10.1016/0002-9343(80)90359-9

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  17 in total

Review 1.  Pulmonary complications of intravenous drug misuse. 1. Epidemiology and non-infective complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

2.  Health conditions among aging narcotics addicts: medical examination results.

Authors:  Yih-Ing Hser; Lillian Gelberg; Valerie Hoffman; Christine E Grella; William McCarthy; M Douglas Anglin
Journal:  J Behav Med       Date:  2004-12

Review 3.  Pulmonary complications of intravenous drug misuse. 2. Infective and HIV related complications.

Authors:  C R Hind
Journal:  Thorax       Date:  1990-12       Impact factor: 9.139

Review 4.  Medical complications of intravenous drug use.

Authors:  M D Stein
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

Review 5.  AIDS and the lung. 4-- Non-invasive investigation of pulmonary disease in patients positive for the human immunodeficiency virus.

Authors:  A B Millar; D M Mitchell
Journal:  Thorax       Date:  1990-01       Impact factor: 9.139

Review 6.  The effects of opiates on the lung.

Authors:  P N Lao
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 7.  Respiratory toxicities from stimulant use.

Authors:  T E Albertson; W F Walby
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

8.  Pulmonary talc granulomatosis mimicking Pneumocystis carinii pneumonia.

Authors:  R N O'Connor; R C Brunham; D H Bowden
Journal:  CMAJ       Date:  1988-01-01       Impact factor: 8.262

9.  Lung function abnormalities in patients infected with the human immunodeficiency virus with and without overt pneumonitis.

Authors:  R J Shaw; C Roussak; S M Forster; J R Harris; A J Pinching; D M Mitchell
Journal:  Thorax       Date:  1988-06       Impact factor: 9.139

10.  Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV.

Authors:  M Bradley Drummond; Gregory D Kirk; Erin P Ricketts; Meredith C McCormack; J Christian Hague; John F McDyer; Shruti H Mehta; Eric A Engels; Robert A Wise; Christian A Merlo
Journal:  BMC Pulm Med       Date:  2010-05-11       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.